Signals, Powered By EquityPandit
A leadership recast has been announced by the drug major Sun Pharma in its Indian and North American operations with naming Abhay Gandhi as CEO of its North American business.
The CEO of North American business, Kal Sundaram, will be moving to India as CEO (India and emerging markets).
The firm has said in a statement that “Effective August 2016, Abhay Gandhi, CEO of India and sub-continent business, will take over as CEO, North America business, Sun Pharma…. Additionally, effective January 2017, Kal Sundaram, currently CEO, North America business will assume the position of CEO, India and emerging markets.”
These are subject to the regulatory approvals.
